Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
103.40    0.00 (0.00%)
Bid:
101.40
Ask:
105.40
Spread: 4.00 (3.945%)
Market Cap: £720.03m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Board Changes

1 Mar 2021 07:01

RNS Number : 6058Q
GlobalData PLC
01 March 2021
 

1 March 2021

 

GlobalData Plc

("GlobalData" or the "Company")

Board Changes

GlobalData, the global provider of data, analytics and insights, is today announcing certain Board changes.

GlobalData Plc announces the appointment of Catherine Birkett to the Board as an independent Non-Executive Director. She will join GlobalData on Monday 8 March 2021. Catherine is currently the Chief Financial Officer of GoCardless Limited, a high growth fintech business. Catherine has had a distinguished career in senior finance roles, including 14 years as Chief Financial Officer at Interoute Telecommunications, during which time the company grew from a small start-up to one of Europe's fastest growing telecoms providers, with revenues in excess of €700m. Catherine will succeed Murray Legg as Chair of the Audit Committee following the AGM.

 In accordance with Schedule 2(g) of the AIM Rules for Companies, Catherine Birkett is 47 years old. In the last 5 years she has held directorships at Interoute Communications Holdings Limited and affiliated companies.

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

Mike Danson, Chief Executive of GlobalData, commented:

"I am delighted to be welcoming Catherine to the team and I am confident that her knowledge and financial experience in high growth companies will be a great asset. I look forward to her joining the team as we seek to exploit the opportunities that lie in front of us.''

 

ENQUIRIES:

GlobalData Plc

Mike Danson, Chief Executive Officer 0207 936 6400

Graham Lilley, Chief Financial Officer

Brokers

Bill Hutchings/ Mose Adigun - J.P. Morgan Cazenove (Nomad and joint broker) 0207 742 4000

Sam Barnett - HSBC (Joint broker) 0207 991 8888

Erik Anderson/ Alina Vaskina - Panmure Gordon (Joint Broker) 020 7886 2500

Hudson Sandler

Nick Lyon 0207 796 4133

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZGZZGRRGMZZ
Date   Source Headline
24th Jan 20247:00 amRNSInvestor and Analyst Seminar
11th Jan 20247:00 amRNSTrading Update & Announcement of Investor Seminar
29th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSInvestment in Healthcare Division by Inflexion
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 202310:48 amRNSDirector/PDMR Shareholding
13th Sep 202310:41 amRNSDirector/PDMR Shareholding
8th Aug 20235:41 pmRNSDirector/PDMR Shareholding
8th Aug 20235:35 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSHalf Year Results
25th Jul 20232:58 pmRNSResults of General Meeting
7th Jul 20237:00 amRNSNotice of General Meeting
30th Jun 202310:00 amRNSDirector/PDMR Shareholding
25th Apr 20233:34 pmRNSResult of AGM
25th Apr 20237:00 amRNSAGM Trading Update and Notice of AI Seminar
29th Mar 20237:00 amRNSNotice of Annual General Meeting 2023
17th Mar 20236:02 pmRNSAnnual Report for year ended 31 December 2022
27th Feb 20237:00 amRNSFull Year Results
27th Jan 20234:31 pmRNSDirector/PDMR Shareholding
27th Jan 20234:26 pmRNSHolding(s) in Company
27th Jan 20239:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSCapital Markets Day
18th Jan 202311:47 amRNSPDMR Dealing
10th Jan 20237:00 amRNSFull year trading update
10th Nov 20224:41 pmRNSSecond Price Monitoring Extn
10th Nov 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20229:44 amRNSHoling(s) in Company
17th Oct 20228:44 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Sep 202210:59 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompletion of TS Lombard Acquisition
15th Aug 20227:00 amRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS£82m Share Scheme Vests for 146 Employees
10th Aug 20227:00 amRNS£410million Debt Financing Facility
1st Aug 20227:00 amRNSHalf Year Results
20th Jul 20227:00 amRNSAppointment of Joint Broker
15th Jul 20227:00 amRNSNotice of Interim Results
28th Jun 202212:45 pmRNSAnnual Report FY2021
26th Apr 202212:32 pmRNSResults of AGM
4th Apr 20221:14 pmRNSNotice of AGM
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20224:43 pmRNSPDMR Notification
10th Jan 20227:00 amRNSUpdate on FY21 performance and Capital Markets Day
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.